Company intelligence / Profile preview

Spinal Kinetics

Sunnyvale, California, United Statesthespinalkinetics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Spinal Kinetics developed the M6® Artificial Disc, a next-generation spinal implant designed to replicate the natural biomechanics of a healthy intervertebral disc. The M6-C cervical and M6-L lumbar discs have been implanted internationally since 2007/2010, with over 10,000 implants by 2011. In the US, clinical trials were ongoing for FDA approval as of mid-late 2010s. The company was acquired by Orthofix in April 2018.

Therapeutic areas: Neurology
Modalities: Device
Industry: Implantable Medical Devices

Drug pipeline

2 assets

M6-C

Commercial

Indications: Cervical degenerative disc disease

1 more asset in the full pipeline.

Request access →

Partnerships

No major pharmaceutical or biotech partnerships reported; partnered with leading spine surgeons and clinical centers for trials.

Beyond the preview

Go deeper on Spinal Kinetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spinal Kinetics.

Explore the full profile